Nona Biosciences’ Global License and Option Agreement with AstraZeneca

Ropes & Gray advised Nona Biosciences on the deal.Nona Biosciences announced it has entered into a license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for preclinical monoclonal antibodies…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Avatar

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here